No significant systemic exposure.

(To be edited, initial data ST OCT 04) Eye drops, 0,5 mg/mL, used in allergic conjunctivitis. Plasma concentration to low to give rise to systemic effects.

Uneventful use reported in 2 patients with acute porphyria.